ciprofibrate has been researched along with Hypertension in 2 studies
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casanova, MA | 1 |
Medeiros, F | 1 |
Trindade, M | 1 |
Cohen, C | 1 |
Oigman, W | 1 |
Neves, MF | 1 |
Kandoussi, A | 1 |
Martin, F | 1 |
Hazzan, M | 1 |
Noël, C | 1 |
Fruchart, JC | 1 |
Staels, B | 1 |
Duriez, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effect of Alpha Linolenic Acid (ALA) Supplementation on Essential Fatty Acids Profile During Pregnancy Compared to Common Supplements and the Epigenetic Effect on the Newborn[NCT03040856] | 0 participants (Actual) | Interventional | 2022-02-01 | Withdrawn (stopped due to Problems executing the study) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ciprofibrate and Hypertension
Article | Year |
---|---|
Omega-3 fatty acids supplementation improves endothelial function and arterial stiffness in hypertensive patients with hypertriglyceridemia and high cardiovascular risk.
Topics: Adult; Cardiovascular Diseases; Endothelium, Vascular; Fatty Acids, Omega-3; Female; Fibric Acids; H | 2017 |
1 other study available for ciprofibrate and Hypertension
Article | Year |
---|---|
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells.
Topics: Animals; Aorta; Cattle; Cells, Cultured; Clofibric Acid; Cyclosporine; Endothelin-1; Endothelium, Va | 2002 |